202 related articles for article (PubMed ID: 24794893)
21. Efficient siRNA delivery based on PEGylated and partially quaternized polyamine nanogels: enhanced gene silencing activity by the cooperative effect of tertiary and quaternary amino groups in the core.
Tamura A; Oishi M; Nagasaki Y
J Control Release; 2010 Sep; 146(3):378-87. PubMed ID: 20621664
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of carrier-mediated siRNA delivery: lessons for the design of a stem-loop qPCR-based approach for quantification of intracellular full-length siRNA.
Colombo S; Nielsen HM; Foged C
J Control Release; 2013 Mar; 166(3):220-6. PubMed ID: 23313963
[TBL] [Abstract][Full Text] [Related]
23. siRNA delivery with chitosan nanoparticles: Molecular properties favoring efficient gene silencing.
Malmo J; Sørgård H; Vårum KM; Strand SP
J Control Release; 2012 Mar; 158(2):261-8. PubMed ID: 22119955
[TBL] [Abstract][Full Text] [Related]
24. Influence of lipoplex surface charge on siRNA delivery: application to the in vitro downregulation of CXCR4 HIV-1 co-receptor.
Lavigne C; Slater K; Gajanayaka N; Duguay C; Arnau Peyrotte E; Fortier G; Simard M; Kell AJ; Barnes ML; Thierry AR
Expert Opin Biol Ther; 2013 Jul; 13(7):973-85. PubMed ID: 23289797
[TBL] [Abstract][Full Text] [Related]
25. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
26. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
27. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.
Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W
Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909
[TBL] [Abstract][Full Text] [Related]
28. Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.
Kim ID; Lim CM; Kim JB; Nam HY; Nam K; Kim SW; Park JS; Lee JK
J Control Release; 2010 Mar; 142(3):422-30. PubMed ID: 19944723
[TBL] [Abstract][Full Text] [Related]
29. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable copolymers with identical cationic segments and their performance in siRNA delivery.
Qi R; Liu S; Chen J; Xiao H; Yan L; Huang Y; Jing X
J Control Release; 2012 Apr; 159(2):251-60. PubMed ID: 22285552
[TBL] [Abstract][Full Text] [Related]
31. Physicochemical characterization of siRNA-peptide complexes.
Law M; Jafari M; Chen P
Biotechnol Prog; 2008; 24(4):957-63. PubMed ID: 19194904
[TBL] [Abstract][Full Text] [Related]
32. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo.
Choi KM; Kim K; Kwon IC; Kim IS; Ahn HJ
Mol Pharm; 2013 Jan; 10(1):18-25. PubMed ID: 22663765
[TBL] [Abstract][Full Text] [Related]
33. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
Han J; Wang Q; Zhang Z; Gong T; Sun X
Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
[TBL] [Abstract][Full Text] [Related]
34. Efficient and targeted delivery of siRNA in vivo.
Shim MS; Kwon YJ
FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
[TBL] [Abstract][Full Text] [Related]
35. [Research progress on the development of the strategies for siRNAs delivery in vivo].
Tang D; Mao A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
37. A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
Shen Y; Wang B; Lu Y; Ouahab A; Li Q; Tu J
Int J Pharm; 2011 Jul; 414(1-2):233-43. PubMed ID: 21545832
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of polyamidoamine dendrimer/alpha-cyclodextrin conjugate (generation 3, G3) as a novel carrier for small interfering RNA (siRNA).
Tsutsumi T; Hirayama F; Uekama K; Arima H
J Control Release; 2007 Jun; 119(3):349-59. PubMed ID: 17477999
[TBL] [Abstract][Full Text] [Related]
39. Functionalized silicon quantum dots tailored for targeted siRNA delivery.
Klein S; Zolk O; Fromm MF; Schrödl F; Neuhuber W; Kryschi C
Biochem Biophys Res Commun; 2009 Sep; 387(1):164-8. PubMed ID: 19576864
[TBL] [Abstract][Full Text] [Related]
40. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
